Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
InovaDM2: Glargine vs NPH in Hospitalized T2DM Patients
NCT02222623Withdrawn
- Sponsor
- Inova Health System
- Start
- Apr 2015
- Primary completion
- May 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of insulin isophane in type 2 diabetes mellitus (T2DM), sponsored by Inova Health System. Planned start Apr 2015; status: withdrawn.
02
Drugs
insulin isophane
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02222623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02222623.